These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8207813)

  • 1. Mutations in v-Src SH3 and catalytic domains that jointly confer temperature-sensitive transformation with minimal temperature-dependent changes in cellular tyrosine phosphorylation.
    Catling AD; Fincham VJ; Frame MC; Haefner B; Wyke JA
    J Virol; 1994 Jul; 68(7):4392-9. PubMed ID: 8207813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the Src homology domains in morphological transformation by v-src.
    Tian M; Martin GS
    Mol Biol Cell; 1997 Jul; 8(7):1183-93. PubMed ID: 9243500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation in the catalytic domain of pp60v-src is responsible for the host- and temperature-dependent phenotype of the Rous sarcoma virus mutant tsLA33-1.
    Foster R; Martin GS
    Virology; 1992 Mar; 187(1):145-55. PubMed ID: 1310553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of Rous sarcoma virus transformation mutants with differing tyrosine kinase activities to study the relationships between vinculin phosphorylation, pp60v-src location and adhesion plaque integrity.
    Kellie S; Patel B; Wigglesworth NM; Critchley DR; Wyke JA
    Exp Cell Res; 1986 Jul; 165(1):216-28. PubMed ID: 3011478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The v-Src SH3 domain binds phosphatidylinositol 3'-kinase.
    Liu X; Marengere LE; Koch CA; Pawson T
    Mol Cell Biol; 1993 Sep; 13(9):5225-32. PubMed ID: 7689147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the SH3 domain of the src oncogene which decrease association of phosphatidylinositol 3'-kinase activity with pp60v-src and alter cellular morphology.
    Wages DS; Keefer J; Rall TB; Weber MJ
    J Virol; 1992 Apr; 66(4):1866-74. PubMed ID: 1312609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation of Src homology domains in the regulated binding of phosphatidylinositol 3-kinase. A role for the Src homology 2 domain.
    Haefner B; Baxter R; Fincham VJ; Downes CP; Frame MC
    J Biol Chem; 1995 Apr; 270(14):7937-43. PubMed ID: 7713890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant protein phosphorylation at tyrosine is responsible for the growth-inhibitory action of pp60v-src expressed in the yeast Saccharomyces cerevisiae.
    Florio M; Wilson LK; Trager JB; Thorner J; Martin GS
    Mol Biol Cell; 1994 Mar; 5(3):283-96. PubMed ID: 8049521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small deletion in v-src SH3 domain of a transformation defective mutant of Rous sarcoma virus restores wild type transforming properties.
    Dezélée P; Barnier JV; Hampe A; Laugier D; Marx M; Galibert F; Calothy G
    Virology; 1992 Aug; 189(2):556-67. PubMed ID: 1322589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SH3 domain of p56lck is involved in binding to phosphatidylinositol 3'-kinase from T lymphocytes.
    Vogel LB; Fujita DJ
    Mol Cell Biol; 1993 Dec; 13(12):7408-17. PubMed ID: 7504174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.
    Matsuda M; Reichman CT; Hanafusa H
    J Virol; 1992 Jan; 66(1):115-21. PubMed ID: 1370084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.
    Jong SM; Zong CS; Dorai T; Wang LH
    J Virol; 1992 Aug; 66(8):4909-18. PubMed ID: 1321277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner.
    Verderame MF; Kaplan JM; Varmus HE
    J Virol; 1989 Jan; 63(1):338-48. PubMed ID: 2462061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells.
    Maroney AC; Qureshi SA; Foster DA; Brugge JS
    Oncogene; 1992 Jun; 7(6):1207-14. PubMed ID: 1375718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ts Transformation mutants of avian sarcoma virus PRCII: lack of strict correlation between transforming ability and properties of the P105-associated kinase.
    Hirano A; Neil JC; Vogt PK
    Virology; 1983 Feb; 125(1):219-29. PubMed ID: 6187125
    [No Abstract]   [Full Text] [Related]  

  • 18. Transformation and pp60v-src autophosphorylation correlate with SHC-GRB2 complex formation in rat and chicken cells expressing host-range and kinase-active, transformation-defective alleles of v-src.
    Verderame MF; Guan JL; Woods Ignatoski KM
    Mol Biol Cell; 1995 Aug; 6(8):953-66. PubMed ID: 7579711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rous sarcoma virus variants that encode src proteins with an altered carboxy terminus are defective for cellular transformation.
    Wilkerson VW; Bryant DL; Parsons JT
    J Virol; 1985 Aug; 55(2):314-21. PubMed ID: 2991557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of avian retroviruses carrying activated transforming human c-src genes and of steps involved in expression of activated src-PKases in vitro.
    Tanaka A; Salem M; Eckroade RJ; Fujita DJ
    Oncogene Res; 1990; 5(4):305-22. PubMed ID: 2168536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.